| ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
|---|---|---|---|---|---|---|
| GC33722-20mg |
|
120444-71-5 |
Deramciclane (EGIS-3886)
|
0 | C20H31NO | |
| GC33722-10mg |
|
120444-71-5 |
Deramciclane (EGIS-3886)
|
0 | C20H31NO | |
| GC33722-5mg |
|
120444-71-5 |
Deramciclane (EGIS-3886)
|
0 | C20H31NO | |
| GC33722-1mg |
|
120444-71-5 |
Deramciclane (EGIS-3886)
|
0 | C20H31NO | |
| GC33721-20mg |
|
132449-89-9 |
Lesopitron dihydrochloride (E4424)
|
0 | C15H23Cl3N6 | |
| GC33721-10mg |
|
132449-89-9 |
Lesopitron dihydrochloride (E4424)
|
0 | C15H23Cl3N6 | |
| GC33721-5mg |
|
132449-89-9 |
Lesopitron dihydrochloride (E4424)
|
0 | C15H23Cl3N6 | |
| GC33721-1mg |
|
132449-89-9 |
Lesopitron dihydrochloride (E4424)
|
0 | C15H23Cl3N6 | |
| GC33720-20mg |
|
1235560-31-2 |
ABT-639 hydrochloride
|
0 | C20H21Cl2F2N3O3S | |
| GC33720-10mg |
|
1235560-31-2 |
ABT-639 hydrochloride
|
0 | C20H21Cl2F2N3O3S | |
| GC33720-5mg |
|
1235560-31-2 |
ABT-639 hydrochloride
|
0 | C20H21Cl2F2N3O3S | |
| GC33720-1mg |
|
1235560-31-2 |
ABT-639 hydrochloride
|
0 | C20H21Cl2F2N3O3S | |
| GC33719-20mg |
|
10423-37-7 |
Citenamide (AY-15613)
|
0 | C16H13NO | |
| GC33719-10mg |
|
10423-37-7 |
Citenamide (AY-15613)
|
0 | C16H13NO | |
| GC33719-5mg |
|
10423-37-7 |
Citenamide (AY-15613)
|
0 | C16H13NO | |
| GC33719-1mg |
|
10423-37-7 |
Citenamide (AY-15613)
|
0 | C16H13NO | |
| GC33718-20mg |
|
63638-91-5 |
Brofaromine (CGP 11305A)
|
0 | C14H16BrNO2 | |
| GC33718-10mg |
|
63638-91-5 |
Brofaromine (CGP 11305A)
|
0 | C14H16BrNO2 | |
| GC33718-5mg |
|
63638-91-5 |
Brofaromine (CGP 11305A)
|
0 | C14H16BrNO2 | |
| GC33718-1mg |
|
63638-91-5 |
Brofaromine (CGP 11305A)
|
0 | C14H16BrNO2 | |